- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis.
The Duke CTSA KL2 program was recently identified as one of the top program hubs by the Center for Leading Innovation and Collaboration (CLIC). The Duke KL2 program was a top performer in the KL2 education program – Underrepresented measure. The CLIC evaluates programs using a Common Metrics Initiative. In alignment with the CLIC’s current goals, the Duke KL2 program set a goal to increase the
Following the announcement of new FDA guidance on the conduct of clinical trials of medical products during the current COVID-19 pandemic, the Clinical Trials Transformation Initiative (CTTI) last week held a public call for experiences and insights from across clinical trials ecosystem. During this webinar, presenters will provide a summary of that aggregated feedback and offer best practices for
The modern era of health analytics is built on data science. Data science merges computer science with statistics, creating new potential for extracting clinical insight from the exponentially increasing “big” data relevant to our patients’ health. Realizing this potential requires new capabilities and innovative technologies. For effective implementation in a healthcare setting, an Accelerator is
The 11th Annual International Science of Team Science Conference is June 1-4, 2020 at Duke University in Durham, NC! SciTS 2020 will bring together team science practitioners, scholars, and providers from a broad range of disciplines to share and advance the latest evidence-based methods in team collaboration and transdisciplinary science. Speakers and attendees will include investigators
This training provides information regarding the sponsor and investigator requirements for an IND or IDE as well as resources to ensure compliance with FDA regulations. There are two separate training modules that each focus on the requirements for the specific regulatory application that the sponsor or sponsor-investigator holds. Sponsors who hold an IND (for drugs and biologics) can complete the